American Regent, Inc. drug recall: Nitroglycerin injection
Key facts
- Agency
- U.S. Food and Drug Administration (FDA)
- Program
- Drugs
- Classification
- Class I, Class II
- Status
- Ongoing
- Event ID
- 99503
- Recall initiated
- Jul 24, 2026
- Classified by FDA
- Aug 26, 2026
- Posted in Enforcement Report
- Aug 26, 2026
- Recalling firm
- American Regent, Inc.
- Firm location
- Shirley, NY, United States
- Initiated by
- Voluntary: Firm initiated
- Firm notified customers by
- Press Release
- Products in this event
- 12
What to do
Compare the product, lot or serial numbers below with what you have. If you use a prescription drug or medical device in this recall, talk to your pharmacist or health care provider before you stop using it, and follow the firm's instructions.
Reason for recall
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde
What the classification means
- Class I: FDA's most serious category: there is a reasonable probability that using or being exposed to the product will cause serious health problems or death.
- Class II: Using or being exposed to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.
About this recall
The firm started this recall on Jul 24, 2026. FDA classified it 33 days later, on Aug 26, 2026. This recall event covers 12 separate products, each with its own FDA recall number. Distribution reported by FDA: Nationwide within the U.S American Regent, Inc. has 7 recalls in our records.
Recalled products (12)
D-0791-2026 Class II Ongoing
Nitroglycerin injection, USP, 50 mg/10 mL (5 mg/mL), packaged in a) 10 mL vials (NDC 0517-4810-01), b) 25x10mL vials (NDC 0517-4810-25) RX only, AMERICAN REGENT, INC., Shirley, NY 11967.
Codes / lots: Lot #: 24291, Exp. Date: 8/31/2026
Quantity: 98,200 vials
D-0792-2026 Class II Ongoing
Cyanocobalamin injection USP, 1,000 mcg/mL, For IM or SC Use Only, packaged in a) 1 mL Multi-Dose Vial (NDC 0517-0031-01), and b) 25x1 mL Multi-Dose Vials (NDC 0517-0031-25) Rx only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.
Codes / lots: Lot #: 24297, Exp. Date 8/31/2026; 24364, Exp. Date: 10/31/2026;
Quantity: 235,350 vials
D-0793-2026 Class II Ongoing
Cyanocobalamin injection USP, 10,000 mcg/10 mL (1,000 mcg/mL), For IM or SC Use Only, packaged in a) 10 mL Multi-Dose Vial (NDC 0517-0032-01) and b) 25x10 mL Multi-Dose Vials (NDC 0517-0032-25), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.
Codes / lots: Lot #: 25082, Exp. Date: 3/31/2027.
Quantity: 26,450 vials
D-0794-2026 Class II Ongoing
AMINAOCAPROIC ACID INJECTION, USP, 250 mg/mL (5 g/20 mL), packaged in a) 20 mL MULTIPLE DOSE VIAL FOR IV INFUSION (NDC 0517-9120-01), and b) 25x20 mL MULTIPLE DOSE VIALS (NDC 0517-9120-25), Rx Only, American Regent, Inc., Shirley, NY 11967.
Codes / lots: Lot #: 24299, Exp. Date: 8/31/2026.
Quantity: 63,200 vials
D-0795-2026 Class II Ongoing
Atropine Sulfate injection, USP, 1 mg/mL, For intravenous Use, Sterile, packaged in a) 1 mL Single-Dose Vial (NDC 0517-1001-01), and b) 25x1 mL Single-Dose Vial (NDC 0517-1001-25), Rx only, AMERICAN REGENT INC., SHIRLEY, NY 11967.
Codes / lots: Lot #: 24353, Exp. Date: 9/30/2026.
Quantity: 89,775 vials
D-0796-2026 Class II Ongoing
ACETYLCYSTEINE SOLUTION, USP, 10% (100 mg/mL), packaged in a) 4 mL Vial NOT FOR INJECTION (NDC 0517-7504-01), and b) 25x4 mL Vials NOT FOR INJECTION (NDC 0517-7504-25), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.
Codes / lots: Lot #: 24418, Exp. Date: 11/30/2026; 25131, Exp. Date: 3/31/2027; 25349, Exp. Date: 8/31/2027
Quantity: 316,450 vials
D-0797-2026 Class II Ongoing
ACETYLCYSTEINE SOLUTION, USP, 20% (200 mg/mL), packaged in a) 4 mL Vial NOT FOR INJECTION (NDC 0517-7604-01), and b) 25x4 mL Vials NOT FOR INJECTION (NDC 0517-7604-25), Rx only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.
Codes / lots: Lot #: 24426, Exp. Date: 11/30/2026; 25220, Exp. Date: 5/31/2027.
Quantity: 169,200 vials
D-0798-2026 Class II Ongoing
Selenious Acid Injection, USP 12 mcg/2 mL (6 mcg/2mL), For intravenous use, packaged in a) 2mL Single-Dose Vial (NDC 0517-6502-01), and b)10x2mL Single-Dose Vial (NDC 0517-6502-10), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.
Codes / lots: Lot #: 25090, Exp. Date 2/28/2027.
Quantity: 41,680 vials
D-0799-2026 Class II Ongoing
Multrys (Trace Elements Injection 4, USP), For intravenous infusion, packaged in a) 1 mL Single-Dose Vial (NDC 0517-9302-01), and b) 25x1 mL Single-Dose Vials (NDC 0517-9302-25) Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.
Codes / lots: Lot #: 25163, Exp. Date: 4/30/2027.
Quantity: 185,775 vials
D-0800-2026 Class I Ongoing
Papaverine HCl Injection, USP, 60 mg/2 mL (30 mg/mL), packaged in a) 2mL Single-Dose Vial (NDC 0517-4002-01), and b) 25x2mL Single-Dose Vials (NDC 0517-4002-25), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.
Codes / lots: Lot #: 25202, Exp. Date: 11/30/2026.
Quantity: 86,100 vials
D-0801-2026 Class II Ongoing
Tralement (trace elements injection 4*, USP), packaged in a) 1mL Single Dose vials (NDC 0517-9305-01) and b) 5x1mL Single Dose vials (NDC 0517-9305-25), Rx only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.
Codes / lots: Lot #: 25149, Exp. Date: 04/30/2027; 25371, Exp. Date: 09/30/2027.
Quantity: 323,000 vials
D-0802-2026 Class II Ongoing
niCARdipine Hydrochloride Injection, USP, 25 mg/10mL (2.5 mg/mL), packaged in a) 10 mL Single Dose Vial (NDC 72572-470-01) and b) 10x10 mL Single Dose Vials (NDC 72572-470-10), Rx Only, Mfd for: Civica, Inc., Lehi, UT, Mfd by: American Regent, Inc., New Albany, OH 43054.
Codes / lots: Lot #: 25295N0C0, Exp. Date: 04/30/2027.
Quantity: 43,460 vials
Source and freshness
- Source
- U.S. Food and Drug Administration (FDA) Enforcement Report, via the openFDA drug enforcement dataset
- Official notice
- FDA Enforcement Report, event 99503
- Raw record
- openFDA API (JSON)
- Dataset last updated by FDA
- Nov 3, 2026
- Imported by RecallRadar
- Nov 4, 2026
Enforcement Report entries describe recalls FDA has classified. They are not always the same as a company press release. If something here differs from FDA's record, FDA's record is correct — please tell us.